Aug. 29, 2008
As it looks toward a marriage with Genentech Inc. and South San Francisco, Swiss drug maker Roche is filing for divorce from Palo Alto.
Roche plans to move its inflammation business from Palo Alto to Nutley, N.J. — no matter the fate of its plan to buy the rest of Genentech — and could shift its virology business from Palo Alto to South San Francisco. Meanwhile, Roche said it will move its U.S. pharmaceutical commercial operations from Nutley to South San Francisco.
Roche is not disclosing the exact number of jobs that would shift between Palo Alto, South San Francisco and New Jersey. This much, however, is sure: South San Francisco will gain hundreds of jobs, New Jersey will lose hundreds and the Palo Alto operations that employed 3,000 people before Roche took control likely will be shuttered.
Friday, October 30, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment